Application 212220

Type
ANDA
Sponsor
MYLAN PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RIVAROXABANRIVAROXABANTABLET;ORAL2.5MGNoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
71681ORIG2022-08-01